Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 16/20 | 1.00 |
| ▸ | GGPS1 | O95749 | 6/20 | 1.00 |
| ▸ | BCL9 | O00512 | 3/20 | 0.78 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.78 |
| ▸ | MAPT | P10636 | 2/20 | 0.78 |
| ▸ | HPGD | P15428 | 2/20 | 0.78 |
| ▸ | MEN1 | O00255 | 1/20 | 0.78 |
| ▸ | PTGES | O14684 | 1/20 | 0.78 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.78 |
| ▸ | PNLIP | P16233 | 1/20 | 0.78 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.78 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.78 |
| ▸ | USP2 | O75604 | 1/20 | 0.78 |
| ▸ | TP53 | P04637 | 1/20 | 0.78 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.78 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carnosic Acid SCHEMBL9923661 | 0.88 | FDPS (1.00) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| Carnosic Acid SCHEMBL18290359 | 0.88 | FDPS (1.00) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| Carnosic Acid SCHEMBL29390188 | 0.88 | FDPS (1.00) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| Carnosic Acid SCHEMBL12590737 | 0.88 | FDPS (1.00) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| Carnosic Acid SCHEMBL13309664 | 0.88 | FDPS (1.00) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| SCHEMBL30726729 | 0.87 | FDPS (0.77) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| SCHEMBL29349568 | 0.85 | FDPS (0.74) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| SCHEMBL15031246 | 0.85 | FDPS (0.76) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| SCHEMBL29405917 | 0.82 | FDPS (0.80) | FDPSGGPS1BCL9CTNNB1ALDH1A1 | |
| SCHEMBL9923660 | 0.82 | FDPS (0.80) | FDPSGGPS1BCL9CTNNB1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4204144-B1 | METHOD OF PRODUCING A METAL NANOPARTICLE | METALCHEMY LTD (GB) | 2026-03-18 | — | — | EP | disclosed |
| US-12557793-B2 | Bee feeder having labyrinthine passages | TURTLE BEAR HOLDINGS, LLC (US) | 2026-02-24 | — | — | US | disclosed |
| EP-4561368-A1 | STEVIOL GLYCOSIDE COMPOSITIONS WITH IMPROVED PROPERTIES | Purecircle SDN BHD (MY) | 2025-06-04 | — | — | EP | disclosed |
| CN-119546196-A | Steviol glycoside compositions with improved properties | 谱赛科有限公司 | 2025-02-28 | — | — | CN | disclosed |
| US-20250040520-A1 | BEE FEEDER HAVING LABYRINTHINE PASSAGES | TURTLE BEAR HOLDINGS LLC (US) | 2025-02-06 | — | — | US | disclosed |
| US-12150434-B2 | Methods for treating or reducing susceptibility of bees to infection with a bee feeder having labyrinthine passages | TURTLE BEAR HOLDINGS, LLC (US) | 2024-11-26 | — | — | US | disclosed |
| US-12005095-B2 | Eutectic extraction solvents, extraction methods by eutectigenesis using said solvents, and extracts derived from said extraction methods | GIVAUDAN FRANCE NATURALS SAS (FR) | 2024-06-11 | — | — | US | disclosed |
| US-20240114931-A1 | BEVERAGES INCLUDING STEVIOL GLYCOSIDES AND A FOAM SUPPRESSING AGENT | CORN PRODUCTS DEVELOPMENT, INC. | 2024-04-11 | — | — | US | disclosed |
| EP-3843539-B1 | BEE FEEDER HAVING LABYRINTHINE PORTAL | TURTLE BEAR HOLDINGS LLC (US) | 2024-04-10 | — | — | EP | disclosed |
| US-20240057642-A1 | BEVERAGES COMPRISING REB A AND STEVIOL GLYCOSIDES | CORN PRODUCTS DEVELOPMENT, INC. | 2024-02-22 | — | — | US | disclosed |
| US-20230330749-A1 | COMPOSITION AND METHOD | Metalchemy Limited (GB) | 2023-10-19 | — | — | US | disclosed |
| US-11758886-B2 | Method for monitoring bee visits to a bee feeder having labyrinthine passages | TURTLE BEAR HOLDINGS, LLC (US) | 2023-09-19 | — | — | US | disclosed |
| CN-113198203-B | Eutectic extraction solvent, extraction method using the same, and extract produced by the extraction method | 纳图瑞克斯有限公司 | 2023-09-08 | — | — | CN | disclosed |
| CN-116600646-A | Preservative and antimicrobial compositions | 奇华顿股份有限公司 | 2023-08-15 | — | — | CN | disclosed |
| CN-116471946-A | Coloring composition for food products | 奇华顿股份有限公司 | 2023-07-21 | — | — | CN | disclosed |
| EP-4204144-A1 | COMPOSITION AND METHOD | Metalchemy Limited (GB) | 2023-07-05 | — | — | EP | disclosed |
| WO-2022147254-A1 | BEVERAGES INCLUDING STEVIOL GLYCOSIDES AND A FOAM SUPPRESSING AGENT | CORN PRODUCTS DEVELOPMENT, INC. (US) | 2022-07-07 | — | — | WO | disclosed |
| WO-2022147279-A1 | BEVERAGES COMPRISING REB A AND STEVIOL GLYCOSIDES | CORN PRODUCTS DEVELOPMENT, INC. (US) | 2022-07-07 | — | — | WO | disclosed |
| US-20220125730-A1 | METHOD OF MANUFACTURING AN ORALLY DISINTIGRATING TABLET | DEXCEL PHARMA TECHNOLOGIES LTD. (IL) | 2022-04-28 | — | — | US | disclosed |
| WO-2022020464-A1 | MODIFIED RELEASE RAPIDLY DISINTEGRATING COMPOSITIONS OF PROTON PUMP INHIBITORS | ELLODI PHARMACEUTICALS, L.P. (US) | 2022-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12557793-B2 | Bee feeder having labyrinthine passages | WAPL, SARAF, KISS1R | FDPS 2332/4885GGPS1 2652/4885BCL9 2228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.